What 150,000 Transplants Actually Represents

NMDP — the nonprofit that operates the United States national marrow and blood stem cell registry under federal contract — has passed roughly 150,000 transplants facilitated since 1987 through the C.W. Bill Young Cell Transplantation Program.

Large round numbers are easy to print and hard to feel. It is worth being precise about what this one counts.

What the number is

It counts unrelated donor transplants facilitated through the federally funded program over nearly four decades — patients with leukemia, lymphoma, myelodysplastic syndromes, sickle cell disease and other blood disorders who needed blood-forming cells from someone outside their own family.

It is a cumulative total, not an annual one. NMDP currently facilitates more than 7,000 transplants a year. Which means roughly one in twenty of those 150,000 happened in the last twelve months, and the rate has been climbing for most of the program's history.

What the number is not

It is not a count of people cured. A transplant is a treatment with real mortality risk, not a guaranteed outcome, and some of those 150,000 patients did not survive their disease.

It is also not a measure of need met. In the first quarter of fiscal year 2026 alone, more than 8,900 patients searched the registry and just over 4,400 unrelated transplants were facilitated. Searching is not the same as finding, and finding is not the same as reaching transplant — insurance, distance, caregiver support and timing all sit between a matched donor and an actual procedure.

And it says nothing about who was served well. A white patient searching the US registry finds a fully matched unrelated donor roughly 75 to 80 percent of the time. For a Black patient, published estimates sit around 30 percent or lower. The 150,000 includes both groups, and averages hide that.

What it took

Two things, repeated for thirty-nine years.

The first is people joining. In the first quarter of fiscal 2026, more than 36,000 new adult registrants from genetically varied backgrounds were added. Almost none of them will ever be called. The ones who are will hear about it years later, out of nowhere, about a patient they will never meet — which is exactly what happened to Torsten Huber, who read a newspaper article in Germany, registered, and two years later was the match for a seven-month-old in Spokane, Washington.

The second is that the program kept existing. It runs on a federal authorization that has to be renewed, and that renewal is in front of Congress right now. Authorization is not the same as funding; appropriations are decided separately, every year.

The part that scales

There is no version of this where the number grows without more people on the registry, from more ancestral backgrounds than are currently represented.

That is the whole mechanism, and it has not changed since 1987. Somebody signs up on an ordinary day, for no particular reason, and years later it turns out to matter.